SCHEMBL25560852

SCHEMBL25560852

COC(=O)c1cc(-c2cccs2)cnc1Nc1nc(-c2ccsc2)c(CC(C)C)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 1/20 0.38
▸ MAPT P10636 7/20 0.37
▸ NPC1 O15118 3/20 0.37
▸ KDM4E B2RXH2 6/20 0.35
▸ ALDH1A1 P00352 6/20 0.35
▸ KMT2A Q03164 5/20 0.35
▸ RAB9A P51151 4/20 0.35
▸ MEN1 O00255 4/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ CACNA1B Q00975 2/20 0.35
▸ APBA1 Q02410 2/20 0.35
▸ CHEK2 O96017 2/20 0.35
▸ FBP1 P09467 1/20 0.35
▸ OPRK1 P41145 1/20 0.34
▸ NR4A2 P43354 1/20 0.34
▸ PDGFRB P09619 1/20 0.33
▸ PDGFRA P16234 1/20 0.33
▸ NEK2 P51955 1/20 0.33
▸ MCHR1 Q99705 1/20 0.33
▸ HPGD P15428 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25560844 0.92 MAPT (0.43) MAPTNPC1KDM4EALDH1A1KMT2A
SCHEMBL25545357 0.92 MAPT (0.40) MAPTNPC1KDM4EALDH1A1KMT2A
SCHEMBL25547850 0.89 CDK2 (0.40) MAPTNPC1KDM4EALDH1A1KMT2A
SCHEMBL25560981 0.88 MAPT (0.38) MAPTNPC1KDM4EALDH1A1KMT2A
SCHEMBL25546433 0.88 MAPT (0.36) MAPTNPC1KDM4EALDH1A1KMT2A
SCHEMBL25560028 0.87 MAPT (0.38) MAPTNPC1KDM4EALDH1A1KMT2A
SCHEMBL25552243 0.87 MAPT (0.38) MAPTNPC1KDM4EALDH1A1KMT2A
SCHEMBL25545584 0.86 MAPT (0.37) MAPTNPC1KDM4EALDH1A1KMT2A
SCHEMBL25551801 0.86 MAPT (0.35) MAPTNPC1KDM4EALDH1A1KMT2A
SCHEMBL25180342 0.86 MAPT (0.37) MAPTNPC1KDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 AXL 3024/4885MAPT 2231/4885NPC1 2317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback